Safety and efficacy of a new imidazole fungicide, Sertaconazole, in the treatment of fungal vulvo-vaginitis: a comparative study using Fluconazole and Clotrimazole

1. Akins R. An update on antifungal targets and mechanisms of resistance in Candida albicans. Medical Mycology. 2005; 43: 285-318.10.1080/13693780500138971Search in Google Scholar

2. Charlier C, Hart E, Lefort A, Ribaud P, Dromer F, Denning DW, et al. Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother. 2006; 57:384-410.10.1093/jac/dki473Search in Google Scholar

3. National guideline on the management of vulvovaginal candidiasis. Clinical effectiveness group. Sex Transm Infect. 1999; 75 (Suppl 1): S19-20.Search in Google Scholar

4. Espinel-Ingroff An, Pfaller MA. Antifungal agents and susceptibility testing. In: Murray PK, Baron EJ, Pfaller MA, et al. editors. Manual of Clinical Microbiology, 7th ed. Am Soc Microbiology, Washington DC. 1999. p. 1405-14.Search in Google Scholar

5. Croxtall JD, Plosker GL. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology. Drugs. 2009; 69: 339-59.10.2165/00003495-200969030-00009Search in Google Scholar

6. Roongpisuthipong A. Sexually Transmitted Diseases. 4th ed. Roongpisuthipong A, editor. Bangkok, Thailand: MedInfo GD, 2006. p. 183-97.Search in Google Scholar

7. Wang PH, Chao HT, Chen CL, Yuan CC. Single-dose sertaconazole vaginal tablet treatment of vulvovaginal candidiasis. J Chin Med Assoc. 2006; 69:259-63.10.1016/S1726-4901(09)70253-9Search in Google Scholar

8. Seidman LS, Skokos CK. An evaluation of butoconazole nitrate 2% Site Release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infect Dis Obstet Gynecol. 2005; 13:197-206.10.1155/2005/453239Search in Google Scholar

9. Loendersloot EW, Goormans E, Wiesenhaan PE, Barthel PJ, Branolte JH. Efficacy and tolerability of single dose versus six-day treatment of candidal vulvovaginitis with vaginal tablets of clotrimazole. Am J Obstet Gynecol. 1985;152: 953-5.10.1016/S0002-9378(85)80008-9Search in Google Scholar

10. Mendling W, Krauss C, Fladung B. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses. 2004; 47:136-42.10.1111/j.1439-0507.2004.00970.x15078430Search in Google Scholar

11. Gross NT, Arias ML, Moraga M, Baddasarow Y, Jarstrand C. Species distribution and susceptibility to azoles of vaginal yeasts isolated prostitutes. Infect Dis Obstet Gynecol. 2007; 2007:82412.10.1155/2007/82412221641618273407Search in Google Scholar

12. Foongladda S, Haouharn P, Sakulmaiwatana P, Chaiprasert A. Comparative evaluation of Candi Select test and conventional methods for identification of Candida albicans in routine clinical isolates. Mycoses. 2002; 45:75-8.10.1046/j.1439-0507.2002.00728.x12000504Search in Google Scholar

13. Pineda G, Scollo K, Santiso G, Lehmann E, Arechavala A. Isolation of Candida dubliniensis in different clinical samples. Analysis of phenotypical methods to differenciate from Candida albicans. Rev Argent Microbiol. 2008; 40: 211-7. [in Spanish, English abstract]Search in Google Scholar

14. Alvarez MI, Suarez BL, Caicedo LD. Isolation of Candida dubliniensis for the first time in Cali, Columbia, and its identification with phenotyping methods. Mycopathologia. 2009; 167:19-24.10.1007/s11046-008-9145-918622716Search in Google Scholar

15. Chauhan N and Kruppa MD. Standard growth media and common techniques for use with Candida albicans. Methods Mol Biol.2009; 499:197-201.10.1007/978-1-60327-151-6_1819152050Search in Google Scholar

16. Roongpisuthipong A, Sentrakul P, Bhiraleus P, Dusitsin N, Sukroongreung S, Pupaibul K. Itraconzole in the treatment of acute vaginal Candidosis. J Med Assoc Thai. 1992; 75:30-40.Search in Google Scholar

17. Atisook R, Boriboonhirunsarn D, Virojkul W. Sample size. In: Atisook R, Kiriwat O, Boriboonhirunsarn D, Rattikhansuk P, editors. Research Methodology, 4th ed. Bangkok: Royal College of Obstetrician & Gynecologist. 1999. p. 334-446.Search in Google Scholar

18. Lebherz TB, Goldman L, Wiesmeier E, Mason D, Ford LC. A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use. Clin Ther. 1983; 5: 409-16.Search in Google Scholar

19. Studd JW, Dooley MM, Welch CC, Vijayakanthan K, Mowat JM, Wade A, et al. Comparative clinical trial of fenticonazole ovule (600 mg) versus clotrimazole vaginal tablet (500 mg) in the treatment of symptomatic vaginal candidiasis. Curr Med Res Opin. 1989; 11: 477-84.10.1185/03007998909110458Search in Google Scholar

20. Sihvo S, Ahonen R, Mikander H, Hemminki E. Selfmedication with vaginal antifungal drugs: physicians’ experiences and women’s utilization patterns. Fam Pract. 2000; 17:145-9.10.1093/fampra/17.2.145Open DOISearch in Google Scholar

21. Fleury F, Hughes D, Floyd R. Therapeutic results obtained in vaginal mycoses after single-dose treatment with 500 mg clotrimazole vaginal tablets. Am J Obstet Gynecol. 1985; 152:968-70.10.1016/S0002-9378(85)80013-2Search in Google Scholar

22. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismuhes WE, Walsy TJ, et al. Guidelines for treatment of Candidiasis. CID. 2004; 38:161-89.10.1086/38079614699449Search in Google Scholar

23. Rex JH, Walsh TJ, Sobel JD, Filler SG, Pappas PG, Dismukes WE, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis. 2000; 30: 662-78.10.1086/31374910770728Open DOISearch in Google Scholar